All shingles articles
-
NewsSome acute and chronic viral infections may increase the risk of cardiovascular disease
In the weeks following a bout of influenza or COVID, the risk of heart attack or stroke may rise dramatically, and chronic infections such as HIV may increase the long-term risk of serious cardiovascular disease events, according to new, independent research.
-
NewsTwo-dose recombinant shingles vaccine is effective even accounting for prior receipt of live shingles vaccine
A target trial emulation was conducted to assess the effectiveness of recombinant zoster vaccine (RZV) accounting for prior receipt of live zoster vaccine (ZVL) and immunocompetence. The results suggest individuals vaccinated with ZVL should be revaccinated with two doses of RZV.
-
NewsNational study urges expanded vaccine screening in emergency departments
About 49% of people are unaware of one or more vaccines recommended for them. Further, 86% have not received one or more of these vaccines, according to the first national comprehensive vaccine surveillance study conducted in emergency departments.
-
NewsLong-term low-dose antiviral treatment benefits patients with eye disease and pain from shingles
Long-term, low-dose antiviral treatment reduces the risk for potentially vision-damaging bouts of inflammation and infection, as well as pain, which occur when shingles affects the eye, according to new research.
-
NewsStudy finds shingles increased risk of subsequent cognitive decline
A new study has found that an episode of shingles is associated with about a 20 per cent higher long-term risk of subjective cognitive decline, providing support for getting the shingles vaccine to decrease risk of developing shingles.
-
NewsScientists identify key protein behind spread of shingles virus
Scientists have discovered a new evasion strategy used by the varicella zoster virus, which causes chickenpox and shingles, that may allow it to affect tissues far from the original site of infection.
-
NewsLive shingles vaccine still protecting 10 years on - despite waning effectiveness
The effectiveness of live zoster (shingles) vaccine is highest in the first year after vaccination and then wanes substantially, but it continues to provide some protection against shingles ten years after vaccination.
-
OpinionHas a viral contribution to Alzheimer’s disease been in front of our noses this whole time?
The concept that a viral infection may induce pathology in regions far from its active location is gaining traction. Could this phenomenon also be at play in Alzheimer’s disease?